Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists

被引：55

作者：

Ahn, HS ^{[1
]}

Arik, L ^{[1
]}

Boykow, G ^{[1
]}

Burnett, DA ^{[1
]}

Caplen, MA ^{[1
]}

Czarniecki, M ^{[1
]}

Domalski, MS ^{[1
]}

Foster, C ^{[1
]}

Manna, M ^{[1
]}

Stamford, AW ^{[1
]}

Wu, YS ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 14期

关键词：

D O I：

10.1016/S0960-894X(99)00339-X

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of pyrroloquinazolines has been discovered that represent novel small molecule inhibitors of the intramolecular ligand of the thrombin receptor. Analogs were prepared to study the structure-activity relationships of substitution at the N1, N3, and N7 positions of the heterocycle. Compounds 4e and 4f have been identified with IC50's of 56 and 52 nM, respectively. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：2073 / 2078

页数：6

共 50 条

[1] Structure-activity relationships of competitive NMDA receptor antagonists
Cheung, NS
OCallaghan, D
Ryan, MC
Dutton, R
Wong, MG
Beart, PM
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 313 (1-2) : 159 - 162
[2] Androgen receptor antagonists (antiandrogens): Structure-activity relationships
Singh, SM
Gauthier, S
Labrie, F
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (02) : 211 - 247
[3] Chemistry and structure-activity relationships of leukotriene receptor antagonists
Bernstein, PR
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : S220 - S226
[4] Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists
Barrow, JC
Nantermet, PG
Selnick, HG
Glass, KL
Ngo, PL
Young, MB
Pellicore, JM
Breslin, MJ
Hutchinson, JH
Freidinger, RM
Condra, C
Karczewski, J
Bednar, RA
Gaul, SL
Stern, A
Gould, R
Connolly, TM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2691 - 2696
[5] Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists
Lan, RX
Liu, Q
Fan, PS
Lin, SY
Fernando, SR
McCallion, D
Pertwee, R
Makriyannis, A
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) : 769 - 776
[6] Structure-activity relationships of arylbenzofuran H3 receptor antagonists
Gfesser, GA
Faghih, R
Bennani, YL
Curtis, MP
Esbenshade, TA
Hancock, AA
Cowart, MD
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) : 2559 - 2563
[7] Structure-activity relationships of RGD mimetics as fibrinogen-receptor antagonists
Miyashita, M
Akamatsu, M
Ueno, H
Nakagawa, Y
Nishimura, K
Hayashi, Y
Sato, Y
Ueno, T
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1999, 63 (10) : 1684 - 1690
[8] Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen
Butts, Arielle
Martin, Jennifer A.
DiDone, Louis
Bradley, Erin K.
Mutz, Mitchell
Krysan, Damian J.
PLOS ONE, 2015, 10 (05):
[9] Structure-property and structure-activity relationships of phenylferrocene derivatives as androgen receptor antagonists
Ochiai, Kotaro
Fujii, Shinya
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 46
[10] Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor
Nozawa, Dai
Okubo, Taketoshi
Ishii, Takaaki
Kakinuma, Hiroyuki
Chaki, Shigeyuki
Okuyama, Shigeru
Nakazato, Atsuro
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (05) : 1989 - 2005

← 1 2 3 4 5 →